期刊文献+

米索前列醇与缩宫素在预防产后出血的应用研究 被引量:21

Applicationof misoprostol and oxytocin in prevention of postpartum hemorrhage
下载PDF
导出
摘要 目的:比较舌下含服米索前列醇与注射缩宫素在预防阴道分娩产后出血的效果。方法:将500名经阴道分娩的的产妇随机分为两组,一组分娩后舌下含服米索前列醇400μg,另一组分娩后肌肉注射缩宫素10 IU,比较两组在产后出血的发生率、产后出血量、24h血红蛋白下降水平、副作用的发生率、第三产程、需要输血人数。结果:米索前列醇组患者的产后出血的发生率、产后失血量和缩宫素组没有显著差异(7.2%和6.4%,P=0.81;148.21mL和143.02mL,P=0.32),但是米索前列醇组在患者发生严重寒颤和发热的发生率比缩宫素组偏高(严重寒颤:3.6%和0.0%,P=0.004;发热:1.6%和0.4%,P=0.04),有统计学差异。结论:舌下含服米索前列醇400ug与肌肉注射缩宫素10 IU在预防产后出血的效果相当,但舌下含服米索前列醇见效快,用法方便。 Objectives:To compare the effect of sublingual misoprostol with intramuscular oxytocin for pre-vention of postpartum hemorrhage (PPH)in vaginal birth.Methods:500 women without risk of PPH were random-ly divided into two groups.One group was allocated to receive 400 ug of misoprostol sublingually and the other group 10 IU of oxytocin intramuscularly.The incidence of PPH,the amount of PPH,drop in hemoglobin level in 24 hours,the incidence of adverse effects,duration of third stage and need for blood transfusion were compared.Re-sults:Incidence of postpartum hemorrhage and postpartum blood loss in the misoprostol group were similar to those in the oxytocin group (7.2% versus 6.4%,P =0.81;148.21 mL versus 143.02 mL,P =0.32).Shivering and pyrexia were encountered more often in the misoprostol than in the oxytocin group (shivering:3.6% versus 0.0%, P =0.004,pyrexia:1.6% versus 0.4%,P =0.04).Conclusion:The efficacy of 40 ug of misoprostol adminis-tered sublingually was equivalent to that of 10 units of oxytocin given intramuscularly for prevention of PPH in vagi-nal delivery.But the effect of misoprostol administered sublingually is faster than oxytocin given intramuscularly, which is more convenient.
出处 《中国性科学》 2015年第5期99-101,共3页 Chinese Journal of Human Sexuality
基金 湖北省教育科学"十二五"规划课题资助项目(2013B308)
关键词 产后出血 米索前列醇 缩宫素 副作用 Postpartum hemorrhage Misoprostol Oxytocin Adverse effects
  • 相关文献

参考文献15

二级参考文献64

  • 1杨梦庚.子宫收缩乏力性产后出血的防治[J].中国实用妇科与产科杂志,1993,9(4):197-199. 被引量:128
  • 2.Zhang Ling-mei,DingHui.(BeiJing Municipal Institute for Women HealthCare , 100006.).全国孕产妇死亡监测结果分析[J].中华妇产科杂志,1994,29(9):514-517. 被引量:197
  • 3邓小燕,叶华萍,邱小燕.米索前列醇联合缩宫素防治产后出血的临床观察[J].实用医学杂志,2006,22(12):1472-1472. 被引量:31
  • 4赵光俊,张启兰,杜鹃,薛夫营,陈桂英,尧良清,谢庆煌,郭晓玲,杨虹,何文倩.米索前列醇用于晚期妊娠引产的临床研究[J].现代妇产科进展,1997,6(2):150-152. 被引量:97
  • 5戴钟英.关于产后出血问题的讨论[J].中华妇产科杂志,1987,22(6):363-363.
  • 6全国孕产妇死亡专题调研协作组.全国21省、市、自治区地区性孕产妇死亡原因分析[J].中华妇产科杂志,1986,21(4):195-195.
  • 7Quiroga Díaz R,Cantú Mata R,Tello Gutiérrez HE,et al.Intrauterine misoprostol for the prevention of bleeding cesarean[J].Ginecol Obstet Mex,2009,77(10):469-474.
  • 8Mansouri HA,Alsahly N.Rectal versus oral misoprostol for active management of third stage of labor:a randomized controlled trial[J].Arch Gyecol Obstet,2011,283(5):935-939.
  • 9Rath WH.Postpartum hemorrhage-update on problems of definitions and diagnosis[J].Acta Obstet Gynecol Scand,2011,90(5):421-428.
  • 10Allen R,O'Brien BM.Uses of misoprostol in obstetrics and gynecology[J].Rev Obstet Gynecol,2009,2(3):159-168.

共引文献237

同被引文献120

二级引证文献88

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部